(SQNM - Get Report)
is a diagnostic testing and genetics analysis company committed to providing products, services, diagnostic testing, applications and genetic analysis products. The stocks is up 34 cents, or 6.4%, at $5.66 in recent trading.
Volume: 4.4 million
Average Volume: 1.5 million
Volume % Change: 187.8%
Ratings: Of 11 analysts covering the stock, seven rate it a buy, three rate it a hold, and one rates it a sell. TheStreet Ratings has a D- sell rating on Sequenom.
Sequenom shows up on a recent list of the
10 Most Shorted Stocks in Biotech
and was one of
11 Stocks Loved or Hated by Hedge Funds
in the most recently reported quarter.
(MSB - Get Report)
is a grantor trust in the U.S. The stocks is up 37 cents, or 1.6%, at $24.16 in recent trading.
Average Volume: 115,800
Volume % Change: 105.8%
Ratings: The single analyst covering Mesabi rates it a moderate buy. TheStreet Ratings has a B- buy rating on the stock.
Mesabi is one of the
top-yielding financial services stocks
(HALO - Get Report)
is a biopharmaceutical company, which is dedicated to the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The stocks is trading up 16 cents, or 2.6%, at $6.25 in recent trading.
Average Volume: 490,200
Volume % Change: 95.2%
Ratings: Of 10 analysts covering the stock, eight rate it a buy, and two rate it a hold. TheStreet Ratings has a D- sell rating on Halozyme.
is a biopharmaceutical company that focuses on the discovery, development and commercialization of innovative treatments for infectious diseases. The stocks is trading up 8 cents, or 1.4%, at $5.90.
Volume: 1.2 million
Average Volume: 600,300
Volume % Change: 89.27%
Ratings: Of 13 analysts covering the stock, 11 rate it a buy, and two rate it a hold. TheStreet Ratings has an E+ sell rating on Achillion.
Acillion shows up on a recent list of
10 Hep C Stocks on Wall Street's Watch List
Follow Stockpickr on
and become a fan on